Key result
Chemotherapy for primary cardiac lymphoma ends in fatal low-output syndrome in a 69-year-old man.
Why the study?
Primary cardiac lymphoma is very rare and generally regarded to have a poor prognosis.
Case Report (n=1)
Primary cardiac lymphoma is a rare condition with a poor prognosis, highlighting the potential need for early diagnosis to improve outcomes.
Answers are grounded in this paper and cite their sources.
Highlights fatal chemotherapy complications in primary cardiac lymphoma; leaves open optimal timing and regimens for prospective evaluation.
Primary cardiac lymphoma, which is very rare, is generally regarded to have a poor prognosis. A case of a 69-year-old man with primary cardiac lymphoma diagnosed by antemortem examination is reported. A computed tomography scan of the chest demonstrated a huge right atrial mass with invasion into the other chambers. No mediastinal lymphadenopathy was detected. Cytologic analysis of pericardial effusion revealed diffuse large B-cell type non-Hodgkin malignant lymphoma. The patient died on the 18th day of chemotherapy (cyclophosphamide, hydroxydaunomycin, oncovin, and prednisone) due to low-output syndrome and multiple organ failure. At autopsy, massive gray-white tumor almost occupied the right atrium and invaded the right inferior lobe of the lung. Although prognosis of primary cardiac lymphoma remains poor, early diagnosis may improve the prognosis.
No takes yet. Share an insight, caveat, or question.
Saotome et al. (2002) conducted a case report in Primary cardiac lymphoma (n=1). Chemotherapy (cyclophosphamide, hydroxydaunomycin, oncovin, and prednisone) was evaluated. A 69-year-old man with primary cardiac lymphoma died on the 18th day of chemotherapy due to low-output syndrome and multiple organ failure.
Synapse has enriched 10 related papers. Consider them for comparative context: